首页> 外文OA文献 >Cost Analysis of Voriconazole Versus Liposomal Amphotericin B And Caspofungin For Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients In Lebanon

【2h】

Cost Analysis of Voriconazole Versus Liposomal Amphotericin B And Caspofungin For Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients In Lebanon

机译：Voriconazole与脂质体两性素B和Caspofungin的成本分析，用于黎巴嫩高危血液癌患者侵袭性曲霉病的原发性治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
G Helou; C Gao; M Xue; N Tarcha; C Charbonneau;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. COST ANALYSIS OF VORICONAZOLE VERSUS LIPOSOMAL AMPHOTERICIN B AND CASPOFUNGIN FOR PRIMARY THERAPY OF INVASIVE ASPERGILLOSIS AMONG HIGH-RISK HEMATOLOGIC CANCER PATIENTS IN LEBANON [J] . Helou G., Gao C., Xue M., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：静脉曲张抗脂质体两性霉素B和卡泊芬净治疗黎巴嫩高危血液病患者的侵袭性菌病的原发性治疗费用分析
2. Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy. [J] . Hachem RY, Boktour MR, Hanna HA, Cancer: A Journal of the American Cancer Society . 2008,第6期

机译：两性霉素B脂质复合物与脂质体两性霉素B单一疗法治疗血液系统恶性肿瘤的侵袭性曲霉病。
3. Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain [J] . Santiago Grau, Jose Ramon Azanza, Isabel Ruiz, ClinicoEconomics and Outcomes Research . 2016,第67期

机译：伏立康唑和阿尼芬净联合抗真菌药与伏立康唑单药联合治疗西班牙侵袭性曲霉病的成本效益分析
4. Is Primary Chemotherapy Useful for AiS Patients with Primary Invasive Breast Cancer [C] . S.M. Scholl, P. Beuzeboc, A.L. Harris, International Conference on "Adjuvant Therapy of Primary Breast Cancer" . 1998

机译：是主要的化疗，可用于AIS患有原发性侵袭性乳腺癌的患者
5. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
6. Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain [O] . Helmut Ostermann, Carlos Solano, Isidro Jarque, 2014

机译：伏立康唑与脂质体两性霉素B在德国和西班牙的血液系统疾病患者中进行侵袭性曲霉病的主要治疗的成本分析
7. Cost Analysis of Voriconazole Versus Liposomal Amphotericin B And Caspofungin for Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients In Saudi Arabia [O] . AA Thaqafi, M Xue, F Farahat, 2015

机译：伏立康唑与脂质体两性素B和Caspofungin对沙特阿拉伯高危血液癌患者侵袭性曲霉病初级治疗的成本分析

Cost Analysis of Voriconazole Versus Liposomal Amphotericin B And Caspofungin For Primary Therapy of Invasive Aspergillosis Among High-Risk Hematologic Cancer Patients In Lebanon

著录项

引文网络

相似文献

相关主题

期刊订阅